● Recruiting

Evaluation of dAroLutamide Addition to anDrogen Deprivation Therapy and radIatioN Therapy in Newly Diagnosed Prostate Cancer With Pelvic Lymph Nodes Metastases

Condition: Prostate Cancer · Sponsor: Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie

PhasePhase 3

Planned participants152

Who can joinMale, 18 Years to 120 Years

Healthy volunteersNo

About this study

Prospective, multicenter, comparative, randomized placebo-controlled Phase III trial - patients with hormone-naïve prostate cancer and pelvic lymph nodes metastases

This description comes directly from the study's public registry record.

Talk to the study team

Ishak Senouci · 0766185461 · ishak.senouci@association-artic.org

Always discuss trial participation with your own doctor first.

Locations (1)

Pôle Santé Léonard de Vinci

Chambray-lès-Tours, France

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05116475